Scotiabank lowered the firm’s price target on Andlauer Healthcare (ANDHF) to C$43 from C$44.50 and keeps a Sector Perform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANDHF:
- Andlauer Healthcare Group Declares First Quarter Dividend
- Andlauer Healthcare Group Forms Joint Venture with NowPac
- Andlauer Healthcare price target raised to C$44.50 from C$44 at Scotiabank
- Andlauer Healthcare price target lowered to C$53 from C$54 at TD Securities
- Andlauer Healthcare Group Reports Stable 2024 Earnings